May 7, 2020 / 3:50 PM / 18 days ago

BRIEF-Gilead Announces Approval Of Veklury (Remdesivir) In Japan For Patients With Severe Covid-19

May 7 (Reuters) - Gilead Sciences Inc:

* GILEAD ANNOUNCES APPROVAL OF VEKLURY® (REMDESIVIR) IN JAPAN FOR PATIENTS WITH SEVERE COVID-19

* GILEAD SCIENCES INC - EXCEPTIONAL APPROVAL IS BASED ON DATA FROM GLOBAL CLINICAL TRIALS AND GILEAD’S COMPASSIONATE USE PROGRAM

* GILEAD SCIENCES INC - GILEAD CONTINUES TO WORK WITH GLOBAL REGULATORY AUTHORITIES TO ENSURE APPROPRIATE ACCESS TO REMDESIVIR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below